PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced that it ...

The director of solid tumor therapy at Stanford Medicine describes how cellular therapies are transforming cancer care.

Earlier this month, the Fulford family was in crisis mode after a pipe burst in the middle of the night. Cold water fell from ...

Lexicon Pharmaceuticals (NASDAQ:LXRX) said the FDA has declined to approve its drug Zynquista, also known as sotagliflozin, ...

The company also announced that it has decided to pursue a full separation of FedEx Freight through the capital markets, ...

Aadi Bioscience (AADI) announced that Kaken Pharmaceutical, an R&D driven pharmaceutical company in Japan, has entered into a stock ...

Dong-A ST (CEO: Jeong Jae-hoon, KRX: 170900) proudly announces that its Stelara biosimilar, IMULDOSA (Project Name: DMB-3115, Active Ingredient: Ustekinumab), has received marketing authorization from ...

The FDA has a period of 30 days to review the IND application ... at 18:30 Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE ...

Zoetis (ZTS) stock falls as FDA notifies about adverse events in dogs treated with the company's pain therapy Librela. Read more here.

The Saskatchewan Rivers School Division board and Elder’s Council hosted their Fall Pipe Ceremony and Feast at Victor Thunderchild High School on Monday.

Palvella Therapeutics to debut on Nasdaq under the ticker symbol "PVLA” as a publicly traded rare disease biopharmaceutical ...

The US FDA has granted clearance to SpliceBio’s IND application to begin the trial of SB-007, designed for Stargardt disease treatment.